Skip to Content
Contact DCTD
Show menu
Search this site
Last Updated: 04/14/2016

2016 American Association for Cancer Research (AACR) Annual Meeting

Schedule of DCTD Presentations

Several DCTD staff members will present information at the AACR Annual Meeting External Link in New Orleans, LA from April 16-20, 2016 via the following three presentation categories:

Oral Presentations

Time Title Presenter Location
Saturday, April 16
5:45 PM - 6:00 PM Careers in Clinical and Translational Cancer Research External Link Jeffrey A. Moscow, Cancer Therapy Evaluation Program Carondelet Room, New Orleans Marriott
Sunday, April 17
1:00 PM - 2:00 PM Funding Opportunities from the Recalcitrant Cancer Research Act of 2012 – Therapeutic development and mechanisms of resistance in SCLC External Link Suzanne Forry, Developmental Therapeutics Program and Peter Ujhazy, Translational Research Program Room 352, Morial Convention Center
Monday, April 18
1:00 PM - 3:00 PM NCI Center for Strategic Scientific Initiatives (CSSI) Programs and Related NCI Opportunities, Tools, and Resources External Link Paula M. Jacobs, Cancer Imaging Program Room 352, Morial Convention Center
Tuesday, April 19
10:30 AM - 10:48 AM Clinical activity, immune and viral correlates of PD-1 blockade with pembrolizumab as first systemic therapy in patients with advanced Merkel cell carcinoma External Link Abstract CT096; Room 391,
Morial Convention Center
10:30 AM -12:15 PM Funding Opportunities for Cancer Research at Multiple NIH Institutes and Centers with NIH Experts External Link Julia T. Arnold, Translational Research Program Room 352, Morial Convention Center
12:30 PM - 2:15 PM Technology Transfer and Intellectual Property: Financial and Career Opportunities for Researchers External Link Jason V. Cristofaro, Office of the Director Room 352, Morial
Convention Center

Poster Presentations

Time Title Location
Sunday, April 17
1:00 PM - 5:00 PM Building better cell models for screening oncology compounds External Link Abstract 605; Section 28;
Poster Board 6
1:00 PM - 5:00 PM Similar 3D pharmacodynamic (3D-PD) responses of human tumor spheroids and xenografts to topoisomerase 1 inhibitor-induced DNA damage External Link Abstract 606; Section 28;
Poster Board 7
1:00 PM - 5:00 PM CellMiner, a systems pharmacological web-application for the NCI-60 cancerous cell-lines: Updates, data integration, and translationally relevant results External Link Abstract 75; Section 3;
Poster Board 15
5:30 PM - 5:45 PM Results from a phase I/II study with the HDAC inhibitor entinostat in combination with high-dose interleukin-2 in renal cell carcinoma patients (CTEP#7870) External Link Abstract CT015 Room 291,
Morial Convention Center
Monday, April 18
8:00 AM - 12:00 PM New NCI experimental therapeutics program (NExT) small molecule libraries for academic investigator hts projects External Link Abstract 1350; Section 20;
Poster Board 9
8:00 AM - 12:00 PM Impact of biospecimen pre-analytical factors on molecular analysis External Link Abstract 1377; Section 21;
Poster Board 8
8:00 AM -12:00 PM The program for cancer detection, diagnosis, and treatment technologies for global health: Translating affordable, minimally invasive point-of-care technologies to less-resourced settings External Link Abstract 1428; Section 23;
Poster Board 4
1:00 PM - 5:00 PM Late-Breaking Research: Tumor Biology 2
The genetic landscape of Wilms tumor
External Link
Abstract LB-180; Section 11
1:00 PM - 5:00 PM NCI 9455: Phase II study of trametinib followed by trametinib plus AKT inhibitor,GSK2141795 in patients with advanced triple negative breast cancer External Link Abstract LB-216; Section 12
Tuesday, April 19
1:00 PM - 5:00 PM NCI-molecular analysis for therapy choice (NCI-MATCH) clinical trial: interim analysis External Link Abstract CT101; Section 13
Wednesday, April 20
8:00 AM -12:00 PM Selective inhibition of DNA methyltransferases and efficacy of novel DNMT inhibitors in leukemia xenografts External Link Abstract 4722; Section 17;
Poster Board 3
8:00 AM -12:00 PM Normal tissue and data resources for cancer research from the GTEx program External Link Abstract 4500; Section 5;
Poster Board 14
8:00 AM -12:00 PM The National Cancer Institute's biospecimen research database: A community resource for improving specimen quality External Link Abstract 5264; Section 37;
Poster Board 1
8:00 AM -12:00 PM Determinants of response to temozolomide in an exceptionally sensitive patient derived model External Link Abstract 5178; Section 33;
Poster Board 4

Meet-the-Expert Presentations

NCI Exhibit Booth # 1012

Time Topic Presenter
Sunday, April 17
2:15-2:45pm Specialized Programs of Research Excellence (SPOREs): A funding mechanism for translational research at the National Cancer Institute Steven Nothwehr, PhD
3:00-3:30pm NCI Exceptional Responders Initiative Barbara Conley, MD
Monday, April 18
1:15-1:45pm NCI’s Experimental Therapeutics Clinical Trials Network Jeffrey Moscow, MD
3:30-4:00pm Immune Checkpoint Inhibitors in Cancer Therapy Elad Sharon, MD, MPH
4:15-4:45pm NCI-Supported Biospecimen Resources & Funding Opportunities for Cancer Research Aniruddha Ganguly, PhD
Tuesday, April 19
11:45am-12:15pm Progress and Opportunities in Biospecimen Science Helen Moore, PhD
2:00-2:30pm Small Cell Lung Cancer Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns with Gene and microRNA Expression Beverly Teicher, PhD
2:45-3:15pm Assay Validation For High Quality Markers For NCI-Supported Clinical Trials: A Cancer Diagnosis Program Funding Opportunity Tawnya McKee, PhD

DCTD Kiosk Activity: NCI Exhibit Booth # 1012

  • Kiosk will be attended by DCTD program Staff.
  • Activities include interacting with prospective and present grantees, distributing program information and funding opportunities, and providing guidance to prepare grant applications.

Kiosk hours are listed below:

Sunday, April 17
1:00 pm – 5:00 pm
Monday, April 18
9:00 am – 5:00 pm
Tuesday, April 19
9:00 am – 5:00 pm
Wednesday, April 20
9:00 am – 12:00 pm